Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure

Overview of attention for article published in Clinical Sarcoma Research, January 2019

Altmetric Badge

About this Attention Score

Among the highest-scoring outputs from this source (#49 of 104)
Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 1 X user

facebook: 2 Facebook pages

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

Chemotherapy regimen for recurrent uterine leiomyosarcoma

Article in Journal of Oncology Pharmacy Practice (October 2023)

Cardiac Safety of Pegylated Liposomal Doxorubicin After Conventional Doxorubicin Exposure in Patients With Sarcoma and Breast Cancer

Article in Cureus (September 2023)

Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model

Article in Nanotheranostics (September 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.